Medindia

X

Publication in the Journal of the National Cancer Institute Demonstrates KRX-0401 (Perifosine) Single-Agent Potential in Neuroblastoma Tumors

Monday, May 17, 2010 General News J E 4
Advertisement
Perifosine observed to be an effective novel agent in neuroblastoma cells in vitro and in vivo

KERYX CONTACT:

Lauren Fischer

Director - Investor Relations

Keryx Biopharmaceuticals, Inc.

Tel: 212.531.5965

E-mail: lfischer@keryx.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Protalix BioTherapeutics Receives Research Grant o...
S
TeamStaff Reports Second Quarter Results